Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma
- 15 December 2001
- Vol. 92 (12) , 2965-2974
- https://doi.org/10.1002/1097-0142(20011215)92:12<2965::aid-cncr10156>3.0.co;2-a
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast CarcinomaLaboratory Investigation, 2000
- HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- HER-2/neu Protein Expression in Breast Cancer Evaluated by ImmunohistochemistryAmerican Journal of Clinical Pathology, 2000
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of PatientsJapanese Journal of Cancer Research, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960